We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aspirin Shown to Reduce Infection Risk

By Biotechdaily staff writers
Posted on 25 Jul 2003
A study has shown that aspirin can reduce the risk of deadly infections by disrupting the bacteria's ability to adhere to host tissue. More...
The finding was reported in the July 15, 2003, issue of the Journal of Clinical Investigation.

Researchers focused on the bacterium Staphylococcus aureus and its role in infections in animal tissue. S aureus is a leading cause of serious systemic infections and abscesses. They found that by disrupting the stress system, aspirin reduced the bacteria's capacity to adhere to host tissue. In addition, the salicylic acid disrupted the ability of S aureus to produce toxins, which the bacteria require to propagate and spread. As a result, the animals treated with aspirin have smaller abscesses and fewer bacteria in the infection. The researchers noted that aspirin did not cure the infection but reduced the ability of the bacteria to cause infection.

"The fact that aspirin has been used for pain treatment, to reduce mortality due to heart attacks, and can possibly reduce the risks of infection is incredible,” said lead author Dr. Ambrose Cheung, professor of microbiology and immunology at Dartmouth Medical School (Hanover, NH, USA).




Related Links:
Dartmouth Medical School

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Steam Sterilizer
Hi Vac II Line
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.